As the most widely used pesticides in the world, fatal incidence of suicidal poisoning by organophosphate compounds is high and is often associated with cardiovascular toxicity. Using the pesticide mevinphos as our tool, we investigated the roles of oxidative stress and nitrosative stress at the rostral ventrolateral medulla (RVLM), the brain stem site that maintains arterial pressure (AP) and sympathetic vasomotor tone, in the cardiovascular depressive effects of organophosphate poisons. Microinjection of mevinphos (10 nmol) into the RVLM of anesthetized Sprague-Dawley rats induced progressive hypotension that was accompanied by an increase (phase I), followed by a decrease (phase II) of an experimental index of baroreflex-mediated sympathetic vasomotor tone, with a fatality rate of 35%. During phase I, there was a preferential upregulation of angiotensin type I receptor (AT1R) messenger RNA (mRNA) and protein that leads to activation of NADPH oxidase (Nox) and increase in superoxide at the RVLM. Pharmacological antagonism of these signals exacerbated fatality and shorted survival time by eliminating baroreflex-mediated sympathetic vasomotor tone, AP, and heart rate. During phase II, there was a progressive upregulation of angiotensin type II receptor (AT2R) mRNA and protein that leads to increase in peroxynitrite in the RVLM, blockade of both sustained brain stem cardiovascular regulation and improved survival. We further found that AT1R and AT2R cross-interacted at transcriptional and signaling levels in the RVLM. We conclude that a transition from AT1R-mediated oxidative stress to AT2R-mediated nitrosative stress in the RVLM underlies the shift from sustained to impaired brain stem cardiovascular regulation that underpins cardiovascular fatality during mevinphos intoxication.
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A 2006 report of the World Health Organization (WHO) (Bertolote et al., 2006) stated that pesticide poisoning is the single most common global means for suicidal use. As the most widely used pesticides in the world, the incidence of suicidal poisoning by organophosphate compounds is understandably high (Bardin et al., 1994) . It is commonly contended that the clinical manifestations of organophosphate poisoning, which vary from salivation, seizure, hypotension, and coma to death (Curtin et al., 2005) , result from accumulation of and overstimulation by acetylcholine (Milatovic et al., 2006) at peripheral or central synapses. Beyond this generalization, detailed cellular and molecular mechanisms that underlie organophosphate poisoning (Costa, 2006) , particularly the elicited cardiovascular depressive effects, are still needed.
Mevinphos (3-[dimethoxyphosphinyl-oxyl]-2-butenoic acid methyl ester), a U.S. Environmental Protection Agency Toxicity Category I organophosphate, is the most commonly used pesticide for suicidal purposes in Taiwan (Chuang et al., 1996; Sheu et al., 1998) . As an organophosphate of the P=O type, mevinphos acts directly on the brain (Takahashi et al., 1991) , and one of the crucial brain sites that mevinphos acts to elicit cardiovascular toxicity (Yen et al., 2001 ) is the rostral ventrolateral medulla (RVLM), which is responsible for maintaining sympathetic vasomotor tone and stable arterial pressure (AP) (Spyer, 1994) . In addition, we found (Chan et al., , 2011 Chang, 2012; Chang et al., 2009; Li et al., 2005) that mevinphos acts on the RVLM to induce an increase (phase I) followed by a decrease (phase II) in the density of the low-frequency (LF) component in the power spectrum of AP signals, which emanates from the RVLM and serves as an index for baroreflex-mediated sympathetic vasomotor tone (Li et al., 2001) . Mechanistically, activation of nitric oxide synthase (NOS) I/nitric oxide (NO) and soluble guanylyl cyclase/ cGMP/protein kinase G cascade in the RVLM is responsible for sustaining brain stem cardiovascular regulation during phase I mevinphos intoxication (Chan et al., 2011; Chang, 2012; Chang et al., 2009) . On the other hand, nitrosative stress indicated by an augmentation of peroxynitrite formed by a reaction between NOS II-derived NO and superoxide FATAL ORGANOPHOSPHATE INTOXICATION leaked from the mitochondrial respiratory chain underlies the impairment of brain stem cardiovascular regulation during phase II Li et al., 2005) .
Several pieces of evidence suggest that the octapeptide angiotensin II (Ang II), a critical mediator of blood pressure regulation (Chan et al., 2005) , may participate in the modulation of the cardiovascular depressive effects of mevinphos via an interaction with NOS I and NOS II in the RVLM. Intracerebroventricular infusion of an agonist of angiotensin type II receptors (AT2R) elicited significant depressor effects (Gao et al., 2011) . On the other hand, intracerebroventricular infusion of Ang II induces hypertension by acting on angiotensin type I receptors (AT1R) in the RVLM, followed by upregulation of NADPH oxidase (Nox) that results in oxidative stress by augmenting superoxide production (Chan et al., 2005) . Ang II induces AT1R-dependent NO production (Javkhedkar et al., 2012) by NOS I and NOS III, whose activities are increased via phosphorylation by mitogenactivated protein kinases (Wang et al., 2011) and decreased via dephosphorylation by protein phosphatases (Zhou et al., 2008) . Overexpression of AT2R markedly increases NOS II expression that leads to apoptosis in cardiomyocytes (Wang et al., 2012) , and enhanced AT2R protein expression reduces Ang II-induced contraction of aorta that is dependent on upregulation of NOS II messenger RNA (mRNA) and protein and subsequent NO generation (Lee et al., 2008) . Finally, a cross talk between AT1R and AT2R, which share a sequence identity of around 30% and have the similar affinity for Ang II (Siragy, 2004) , has been reported.
The present study was undertaken to assess the hypothesis that a transition from AT1R-mediated oxidative stress to AT2R-mediated nitrosative stress in the RVLM underlies the progression from sustained to impaired brain stem cardiovascular regulation during mevinphos intoxication. Based on combined physiological, pharmacological, and biochemical results, this hypothesis was validated. We further showed that a cross talk between AT1R and AT2R also took place during this transition. During phase I mevinphos intoxication, there was an AT1R-mediated downregulation of AT2R and NOS II mRNA in the RVLM. This was shifted to an AT2R-mediated protein phosphatase 2A (PP2A) activation that leads to inhibition of extracellular signal-regulated kinase (ERK) and NOS I phosphorylation in RVLM during phase II.
MATeRIALS AND MeTHoDS
All experimental procedures and handling of animals carried out in this study have been approved by the Institutional Animal Care and Use Committee of the Kaohsiung Chang Gung Memorial Hospital and were in compliance with the guidelines for animal care set forth by this Committee.
Animals. Adult male Sprague-Dawley rats (285-337 g, n = 187) purchased from the Experimental Animal Center of the National Science Council, Taiwan, Republic of China were used. Animals were housed in groups of two to three in individually ventilated cages, in a temperature-controlled room (22 ± 2°C) with 12 h light/12 h dark cycles (lights on at 07:00 h) and with free access to rat chow and water. All efforts were made to minimize animal suffering and to reduce the number of animal used.
General preparation. Preparatory surgery was carried out under an induction dose of pentobarbital sodium (50 mg/kg, ip), of which included cannulation of a femoral artery and a femoral vein, together with tracheal intubation. During the recording session, which routinely commenced 60 min after the administration of pentobarbital sodium, anesthesia was maintained by iv infusion of propofol (Zeneca, Macclesfield, United Kingdom) at 20-25 mg/kg/h. This scheme has been demonstrated previously (Yang et al., 1995) to provide satisfactory anesthetic maintenance while preserving the capacity of brain stem cardiovascular regulation. Body temperature of the animals was maintained at 37°C with a heating pad, and rats were allowed to breathe spontaneously with room air during the entire recording session.
Mevinphos intoxication model. AP signals recorded from the femoral artery were subject to simultaneous on-line power spectral analysis (Chan et al., , 2011 Chang, 2012; Chang et al., 2009; Li et al., 2005) . We were particularly interested in the LF (0.25-0.8 Hz) component of the AP spectrum because it takes origin from the RVLM (Kuo et al., 1997) and the biphasic changes in LF power reflect the waxing (phase I) and waning (phase II) of the baroreflex-mediated sympathetic vasomotor tone (Li et al., 2001 ) during mevinphos intoxication (Chang, 2012) . Heart rate (HR) was derived instantaneously from AP signals. Because mevinphos induces comparable cardiovascular responses when given systemically or directly to the RVLM (Yen et al., 2001 ), our animal model entailed microinjection bilaterally of mevinphos into the RVLM to elicit site-specific effects (Chan et al., 2011; Chang, 2012) . Temporal changes in pulsatile AP, mean AP (MAP), HR, and power density of the LF component were routinely followed for 180 min after the administration of mevinphos, in an on-line and real-time manner (Chan et al., 2011) . The survival rate, survival time, and duration of phases I and II within 180 min after administration of mevinphos were also recorded.
Microinjection of test agents.
Microinjection bilaterally of test agents into the RVLM, each at a volume of 50 nl, was carried out stereotaxically and sequentially (Chan et al., 2011) via a glass micropipette connected to a 0.5-μl Hamilton (Reno, NV) microsyringe. The coordinates used were 4.5-5 mm posterior to lambda, 1.8-2.1 mm lateral to midline, and 8.1-8.4 mm below the dorsal surface of cerebellum. These coordinates were selected to cover the RVLM at which functionally identified sympathetic premotor neurons of the RVLM reside (Ross et al., 1984) . Test agents used included mevinphos (Chem Service, West Chester, PA; purity 95.1%, composed of 83.1% cis and 12.0% trans forms; 10 nmol); AT1R antagonist (Lin et al., 1997) , losartan (Sigma, St Louis, MO; 2 nmol); AT2R antagonist (Lin et al., 1997) , PD123319 (Tocris, Washington, DC; 2 nmol); Nox inhibitor (Chan et al., 2005) , diphenyleneiodonium (DPI; EMD Millipore Corporation, Billerica, MA; 1.5 nmol), superoxide scavenger (Chan et al., 2005) , tempol (EMD Millipore Corporation; 5 nmol); peroxynitrite scavenger (Salvemini et al., 1998) , l-cysteine (Sigma; 100 pmol); active peroxynitrite decomposition catalyst (Trabace and Kendrick, 2000) , 5,10,15,20-tetrakis-(N-methyl-4′-pyridyl)-porphyrinato iron (III) (FeTMPyP; Calbiochem; 50 pmol); or PP2A inhibitor (Fernández-Sánchez et al., 2013) , okadaic acid (OA; Tocris; 5 fmol). All test agents were dissolved in artificial cerebrospinal fluid (aCSF), with the exception of OA, which was prepared with 2% dimethyl sulfoxide (DMSO). All test agents used for pretreatments were given 30 min before the administration of mevinphos. The dose of mevinphos (10 nmol) used in the present study was adopted from Yen et al. (2001) , in which mevinphos elicits comparable cardiovascular responses when applied by iv administration (160 or 320 μg/kg) or microinjection into the RVLM (2 μg). The doses of the other agents were adopted from our previous or other reports (Chan et al., 2005; Chang, 2012; Fernández-Sánchez et al., 2013; Lin et al., 1997; Salvemini et al., 1998; Trabace and Kendrick, 2000) that used those test agents for the same purpose as in this study and were found to effectively inhibit mevinphosinduced cardiovascular responses in preliminary experiments. Application of the same amount of aCSF or 2% DMSO served as the vehicle control to control for possible volume effect of microinjection. The composition of aCSF was (mM): NaCl 117, NaHCO 3 25, glucose 11, KCl 4.7, CaCl 2 2.5, MgCl 2 1.2, and NaH 2 PO 4 1.2. To avoid the confounding effects of drug interactions, each animal received only one pharmacological treatment.
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Collection of tissue samples from the RVLM. We routinely collected tissue samples for subsequent biochemical evaluations (Chan et al., 2011; Chang, 2012) during the peak of phase I (30 min) or phase II (180 min) after microinjection of mevinphos into the RVLM (experimental group) or 30 or 180 min after microinjection of aCSF or 0.2% DMSO (vehicle control group). Animals were killed with an overdose of pentobarbital sodium and tissues from both sides of the medulla oblongata, at the level of the RVLM (0.5-1.5 mm rostral to the obex), were collected by micropunches made with a 1-mm (id) stainless steel bore to cover the anatomical boundaries of the RVLM. Medullary tissues collected from anesthetized animals but without treatment served as the sham controls. The concentration of total proteins extracted from those tissue samples was determined by the BCA protein assay (Pierce, Rockford, IL).
Determination of AT1R and AT2R protein expression. Western blot analysis of AT1R, AT2R, or β-actin was carried out on proteins extracted from the RVLM. The primary antisera used included a rabbit polyclonal antiserum against AT1R (EMD Millipore Corporation) or AT2R (EMD Millipore Corporation) or a mouse monoclonal antiserum against β-actin (Chemicon, Temecula, CA). This was followed by incubation with horseradish peroxidase-conjugated donkey anti-rabbit immunoglobulin G (IgG) (GE healthcare, Uppsala, Sweden) for AT1R or AT2R or sheep anti-mouse IgG (Amersham Biosciences) for β-actin. Specific antibody-antigen complex was detected, and the amount of protein product was quantified by Bio-Rad ChemiDoc XRS image system and software (Bio-Rad, Hercules, CA) and was expressed as the ratio to β-actin protein.
Distribution of AT1R and AT2R in neurons.
We employed double immunofluorescence staining coupled with laser scanning confocal microscopy to detect localization of AT1R and AT2R in RVLM neurons, using a rabbit polyclonal antiserum (Santa Cruz Biotechnology, Dallas, TX) against AT1R or AT2R and a mouse monoclonal antiserum against a specific neuron marker, NeuN (Millipore, Billerica, MA). The secondary antisera (Molecular Probes, Eugene, OR) used included a goat anti-rabbit IgG conjugated with Alexa Fluor 488 for AT1R or AT2R and a goat anti-mouse IgG conjugated with Alexa Fluor 568 for NeuN. Tissues similarly processed but omitting the primary antiserum against AT1R or AT2R served as our negative controls. Immunoreactivity was viewed under a Fluorview FV10i laser scanning confocal microscope (Olympus, Tokyo, Japan).
Determination of mRNA levels of AT1R, AT2R, NOS I, or NOS II. Total RNA from the RVLM was isolated with TRIzol reagent (Invitrogen). All RNA isolated was quantified spectrophotometrically by determining the ratio of optical density at 260/280 nm. As in our recent study (Chang et al., 2009) , reverse transcriptase reaction was performed for first-strand complementary DNA (cDNA) synthesis. Real-time PCR analysis was performed in duplicate for all the cDNA and for the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) control using protocols reported previously (Chang et al., 2009) . Primers for at1r (GenBank accession NM_030985), at2r (GenBank accession 012494), nos I (GenBank accession NM_052799), nos II (GenBank accession NM_012611), or GAPDH (GenBank accession NM_017008) were designed by the Roche LightCycler_probe design software 3.5 (Roche Applied Science, Mannheim, Germany) using the sequence information of the NCBI database, and oligonucleotides were synthesized by Genemed Biotechnologies (Taipei, Taiwan). The primer pairs for amplification of at1r cDNA were 5′-CCTCTGACTAAATGGCTTACG-3′ for the forward primer and 5′-CATCTATTAATGCAAGACGGC-3′ for the reverse, those of at2r cDNA were 5′-TGGGAGTCTCTGACAGTTC-3′ for the forward primer and 5′-AATGCTTATCTGCCGGT-3′ for the reverse primer, those of nos I cDNA were 5′-AGAGCACACTGGAAACG-3′ for the forward primer and 5′-CCAAATCTCTTAATGGATGAGTAGTAT-3′ for the reverse primer, those of nos II cDNA were 5′-TGGAGGTGCTGGAAGAGTT-3′ for the forward primer and 5′-GGAGGAGCTGATGGAGTAGT-3′ for the reverse primer, and those of GAPDH cDNA were 5′-GCCAAAAGGGTCATCATCTC-3′ for the forward primer and 5′-GGCCATCCACAGTCTTCT-3′ for the reverse primer.
Experimental indices for upregulation of Ang II and activation of AT1R and AT2R. Cell lysate from the RVLM was subject to a commercial kit for ELISA according to the manufacturer's protocol to detect the levels of Ang II by an Angiotensin II ELISA kit (BioVendor, Karasek, Brno, Czech Republic), Nox by a superoxide assay kit coupling with adding of the substrate NADPH (Sigma), and PP2A by a PP2A immunoprecipitation phosphatase assay kit (EMD Millipore Corporation). The final absorbance of the reaction solution at 450 nm was determined by spectrophotometry using an ELISA microtiter plate reader (Anthros Labtec, Salzburg, Austria) and expressed as fold changes against baseline controls. Because Nox is the common downstream target of AT1R (Chan et al., 2005) and PP2A is the downstream target of AT2R (Huang et al., 1996) , an increase in activities of Nox or PP2A was used as our experimental indices for AT1R or AT2R activation.
Experimental indices for oxidative stress and nitrosative stress. An augmentation of superoxide was used as our experimental index for oxidative stress. The levels of superoxide in cell lysate of the RVLM was determined quantitatively by an ELISA based on lucigenin (Santa Cruz Biotechnology) in conjunction with a spectroluminometer (Sirius Luminometer, Berthold, Pforzheim, Germany). A commercial kit for ELISA of Nitrate/Nitrite Colorimetric Assay Kit (Cayman, Ann Arbor, MI) was used according to the manufacturer's protocol to detect the levels of NO in cell lysate of the RVLM. 3-Nitrotyrosine detected by a commercial ELISA (Cell Biolabs, San Diego, CA) is used as an experimental index for peroxynitrite, our experimental index for nitrosative stress (Kahl et al., 2003) .
Measurement of protein levels of ERK, phosphorylated ERK, NOS I, and NOS II.
Commercial kits for ELISA were used to detect ERK1/2 (Cell Signaling Technology, Beverly, MA), phosphorylated ERK1/2 at Thr202/Tyr204 (Cell Signaling Technology), NOS I (Biorbyt, Cambridge, Cambridgeshire, United Kingdom), or NOS II (Cell Signaling Technology) in cell lysate from the RVLM. The final absorbance of the reaction solution was determined by spectrophotometry using an ELISA microtiter plate reader (Anthros Labtec) and expressed as fold changes against control group.
Histology. In some animals that were not used for biochemical analysis, the brain stem was removed at the end of the physiological experiment and fixed in 30% sucrose in 10% formaldehyde-saline solution for at least 72 h. Frozen 25-μm sections of the medulla oblongata mounted in glycerin were used for histological verification of the microinjection sites.
Statistical analysis.
All values are expressed as mean ± SEM. The average value of MAP or HR calculated every 20 min after the administration of test agents or vehicle, the sum of total power density for the LF component in the AP spectrum for 20 min, or the activity or mRNA/protein expression level in the RVLM during each phase of mevinphos intoxication was used for statistical analysis. One-way or two-way ANOVA with repeated measures was used, as appropriate, to assess group means. This was followed by the Scheffé multiplerange test for post hoc assessment of individual means. p < 0.05 was considered to be statistically significant.
ReSULTS

Biphasic Cardiovascular Responses in Mevinphos Intoxication
As reported previously (Chan et al., , 2011 Chang, 2012; Chang et al., 2009) , microinjection bilaterally of mevinphos (10 nmol) into the RVLM of animals pretreated with vehicle elicited progressive hypotension (Fig. 1 ) that became significant 120 min after application, accompanied by insignificant changes in HR. Simultaneous changes in power density of 204 the LF component of AP signals revealed two distinct phases. Phase I entailed a significantly augmented LF power (Fig. 1 ) that peaked at 20-40 min and endured for 100 min to reflect sustained brain stem cardiovascular regulatory functions. Phase II, which lasted the remainder of our 180-min observation period, exhibited further and significant reduction in LF power to below baseline (Fig. 1) to reflect failure of the brain stem cardiovascular regulatory machinery.
Elevation of Ang II and Differential Upregulation of AT1R and AT2R in the RVLM During Mevinphos Intoxication
The fundamental premise for Ang II or AT1R and AT2R in the RVLM to play a critical role in brain stem cardiovascular regulation in our model is for them to be upregulated during mevinphos intoxication. This fundamental premise was investigated in our first series of experiments. Compared with aCSF controls, microinjection bilaterally of mevinphos (10 nmol) into the RVLM significantly increased Ang II level ( Fig. 2A ) in this medullary site during both phases of mevinphos intoxication. However, the mRNA and protein levels of AT1R in the RVLM were only significantly increased during phase I, which returned to baseline during phase II (Figs. 2B, 2D , and 2E). On the other hand, both AT2R mRNA and protein levels were significantly and progressively increased over both phases (Figs. 2C, 2D , and 2F).
Differential Upregulation of AT1R and AT2R in RVLM Neurons
Based on double immunofluorescences staining coupled with laser scanning confocal microscopy, we further evaluated whether the differential changes in AT1R and AT2R expression in the RVLM demonstrated in our biochemical analyses indeed took place at the neuronal level. Compared with basal (Fig. 3A) or aCSF control (data not shown), there was a discernible increase in AT1R immunoreactivity in RVLM neurons stained positively with NeuN during phase I (Fig. 3B ), but not phase II (Fig. 3C ) mevinphos intoxication. On the other hand, the increased AT2R immunoreactivity in RVLM neurons was present during both phases (Figs. 3E and 3F) compared with basal control (Fig. 3D ).
AT1R and AT2R in the RVLM Differentially Affect Brain Stem Cardiovascular Regulation During Mevinphos Intoxication
We further determined whether activation of AT1R or AT2R in the RVLM is casually related to brain stem cardiovascular regulation during mevinphos intoxication. In rats that received pretreatment by bilateral microinjection into the RVLM of a selective nonpeptide antagonist against AT1R, losartan (2 nmol), which prevents AT1R activation (Lin et al., 1997) , there was a significant and dramatic reduction in MAP, HR, and LF power that reached zero 40 min after mevinphos application (Fig. 1) . In contrast, pretreatment with an equimolar dose of a potent, selective, nonpeptide angiotensin AT2R antagonist, PD123319 (2 nmol), which prevents AT2R activation (Lin et al., 1997) , significantly reversed hypotension and blunted the minor bradycardia during both phases, along with further augmentation of the power density of LF component during phase I and amelioration of the reduced LF power during phase II mevinphos intoxication (Fig. 1) . Furthermore, combined losartan (2 nmol) and PD123319 (2 nmol) pretreatment, similar to vehicle controls, did not significantly alter the mevinphos responses (Fig. 1) .
Differential Contribution of AT1R and AT2R in the RVLM to Survival From Mevinphos Intoxication
Microinjection of losartan (2 nmol) into the RVLM (Fig. 4 ) also significantly reduced the survival rate and the survival time by shortening the duration of phase I and prolonging phase II. Conversely, pretreatment with PD123319 (2 nmol) potentiated survival from mevinphos intoxication (Fig. 4) . Again, combined pretreatment with losartan and PD123319 was ineffective (Fig. 4) .
Preferential Activation of Nox by AT1R in the RVLM
Ang II is known to exert a profound regulatory effect on Nox via AT1R activation (Chan et al., 2005) . Indeed, there was a preferential increase in Nox activity in the RVLM during phase I mevinphos intoxication (Fig. 5) , which was significantly blunted by pretreatment with losartan (2 nmol), both losartan and PD123319 (2 nmol), or the Nox inhibitor, DPI (1.5 nmol). However, pretreatment with PD123319 (2 nmol) or the superoxide scavenger, tempol (5 nmol), was ineffective. On the other hand, Nox activity in the RVLM during phase II was comparable in all pretreatment groups (Fig. 5) . It should be mentioned that because animals pretreated with losartan died within 40 min after the administration of mevinphos, no data are presented for Nox activity during phase II. This practice applies to all remaining biochemical investigations in this study on the effects of mevinphos in losartan-pretreated rats.
Oxidative Stress Induced by AT1R/Nox in the RVLM Prevails During Phase I
Nox activation by AT1R is responsible for the production of reactive oxygen species and subsequent oxidative stress (Chan et al., 2005) . Our results revealed that oxidative stress experimentally indicated by a progressive augmentation of superoxide level was present in the RVLM during both phases of mevinphos intoxication (Fig. 5 ) and was significantly blunted by pretreatment with a combination of losartan and PD123319, tempol, or PD123319. Furthermore, the superoxide level during phase I was significantly potentiated in losartan-pretreated animals that died of mevinphos intoxication (Fig. 5) , and blockade by DPI pretreatment was only effective during this phase.
Activation of Nox and Oxidative Stress Sustains Brain Stem Cardiovascular Regulation and Promotes Survival During Mevinphos Intoxication
Pretreatment by bilateral microinjection of DPI (1.5 nmol) or tempol (5 nmol) into the RVLM potentiated hypotension and antagonized the augmented LF power during phase I mevinphos intoxication (Fig. 6) . Furthermore, compared with vehicle controls (66%), the survival rate from mevinphos intoxication of rats pretreated with DPI or tempol was decreased to 35%.
Nitrosative Stress Elicited by AT2R in the RVLM Prevails During Phase II
The next series of experiments delineated whether nitrosative stress is elicited after AT2R activation in the RVLM during mevinphos intoxication. Pretreatment with PD123319 (2 nmol) or a combination of losartan and PD123319 significantly blunted the mevinphos-induced increase in NO and peroxynitrite in the RVLM (Fig. 7) . On the other hand, there was significant potentiation of the NO and peroxynitrite level during phase I in the RVLM of losartan-pretreated rats that died of mevinphos intoxication (Fig. 7) .
Activation of Nitrosative Stress Impairs Brain Stem Cardiovascular Regulation and Promotes Fatality During Mevinphos Intoxication
Pretreatment by bilateral microinjection of the peroxynitrite scavenger, l-cysteine (100 pmol), or the peroxynitrite catalyst, FeTMPyP (50 pmol), into the RVLM significantly antagonized the hypotension, along with potentiation of the augmented LF power during phase I and antagonism of the reduced LF power during phase II mevinphos intoxication (Fig. 8) . Compared with vehicle controls (66%), both pretreatments also prolonged survival from mevinphos intoxication to 85%.
Preferential Activation of PP2A by AT2R in the RVLM
PP2A, which mediates dephosphorylation of protein (Fernández-Sánchez et al., 2013) , is the cellular target and key component of the intracellular pathway coupled to neuronal AT2R activation (Huang et al., 1996) . We found that PP2A activity in the RVLM was progressively augmented during mevinphos intoxication (Fig. 9 ). This augmentation was significantly antagonized by pretreatments with PD123319 (2 nmol), combination of losartan and PD123319, or the PP2A inhibitor, OA (5 fmol), but was potentiated in losartan-pretreated animals that died of mevinphos intoxication (Fig. 9) .
Preferential Inhibition of Phosphorylated ERK or NOS I by PP2A in the RVLM
Our next series of experiments delineated whether PP2A activation by AT2R during mevinphos intoxication results in inhibition of ERK phosphorylation or NOS I activation in the RVLM. We found that pretreatment with PD123319, combination of losartan and PD123319, or OA potentiated the preferential phosphorylation of ERK and activation of NOS I in the RVLM during phase I mevinphos intoxication but were ineffective against NOS II expression (Fig. 9) . On the other hand, losartan pretreatment significantly blunted the phase I increase in ERK phosphorylation (Fig. 9) , although the total protein expression of ERK in the RVLM remained unaltered.
Activation of PP2A Impairs Brain Stem Cardiovascular Regulation and Promotes Fatality During Mevinphos Intoxication
Pretreatment by bilateral microinjection of OA into the RVLM significantly antagonized the hypotension, along with potentiation of the augmented LF power during phase I and antagonism of the reduced LF power during phase II mevinphos intoxication (Fig. 10) . Again, OA pretreatment (83%) prolonged survival from mevinphos intoxication (66%).
AT1R and AT2R Differentially Modulate NOS I and NOS II in the RVLM
Pretreatment with losartan or combination of losartan and PD123319, but not PD123319, significantly antagonized the preferential increase in NOS I mRNA (Fig. 11 ) and protein ( Fig. 9 ) expression during phase I mevinphos intoxication. On the other hand, pretreatment with PD123319 or combination of losartan and PD123319, but not losartan, significantly blunted the progressive augmentation of NOS II mRNA (Fig. 11) and protein ( Fig. 9) expression during both phases. Moreover, the phase II upregulation of NOS II mRNA or protein in the RVLM was significantly potentiated by pretreatment with losartan ( Figs. 9 and 11) . Our last series of experiments determined whether reciprocal inhibition exists between AT1R and AT2R in the RVLM during mevinphos intoxication. Pretreatment with losartan, rather than PD123319, significantly increased AT2R mRNA level during phase I (Fig. 12) . On the other hand, losartan or PD123319 exerted minimal effects on changes in AT1R mRNA during both phases or the upregulated AT2R mRNA during phase II mevinphos intoxication (Fig. 12) .
DIScUSSIoN
Based on a rat model of mevinphos intoxication, the present study provided new mechanistic insights into the cardiovascular toxicity associated with organophosphate poisoning ( Fig. 13) . We demonstrated that superimposed on an increase in Ang II, a transition from AT1R-mediated oxidative stress to AT2R-mediated nitrosative stress in the RVLM underpins the progressive shift from sustained (phase I) to impaired (phase II) brain stem cardiovascular regulation, accompanied by a shift from maintained to depressed AP and HR, which underpins the shift from survival to fatality during mevinphos intoxication. We further showed that a cross talk between AT1R and AT2R also takes place during this transition. During phase I mevinphos intoxication, AT1R-activated upregulation of NOS I and production of superoxide by Nox are accompanied by AT1R-mediated downregulation of AT2R and NOS II mRNA in the RVLM. This was shifted to AT2R-activated upregulation of NOS II and production of peroxynitrite, accompanied by AT2R-mediated PP2A activation that leads to inhibition of ERK and NOS I phosphorylation in RVLM during phase II.
Acute cholinergic crisis elicited by inhibiting acetylcholinesterase is a well-known mechanism for organophosphate poisoning (Costa, 2006; Milatovic et al., 2006; Sultatos, 2007) . Thus, it is likely that mevinphos elicits the cardiovascular responses indirectly via inhibition of acetylcholinesterase in the RVLM. However, that some patients still yield to acute organophosphate poisoning despite repeated dosing of the muscarinic receptor antagonist atropine suggests that cellular mechanisms that are independent of muscarinic activation may also be engaged in organophosphate poisoning (Yen et al., 2000) . Our laboratory Yen et al., 2004) also reported that both cholinergic-dependent and -independent cardiovascular responses are induced by mevinphos. Thus, a novel finding of the present study is that in addition to acetylcholine esterase inhibition (Yen et al., 2000) , AT1R and AT2R in the RVLM present themselves as alternative targets of organophosphate mevinphos. We found that, superimposed on an increase in Ang II levels, the preferential upregulation of AT1R during phase I in the RVLM sustains, and the progressive upregulation of AT2R during both phases impairs brain stem cardiovascular regulation during mevinphos intoxication. Ang II can be produced inside or outside the brain. However, because mevinphos is directly microinjected into the RVLM in the present study, it is conceivable that the increase of Ang II is produced within this brain stem site. Sarkar et al. (2000) reported a link between Ang II and organophosphate by showing that quinalphos decreases fertility in adult male rats via an increase of angiotensin converting enzyme activity in the testis. It is, therefore, conceivable that mevinphos increases Ang II level in the RVLM by the same mechanism.
Our present results showed that activation of AT1R leads to augmented NO production by upregulation of NOS I in the RVLM, which we demonstrated previously (Chang, 2012; Chang et al., 2009) to be responsible for sustaining brain stem cardiovascular regulation during phase I mevinphos intoxication. Four binding sites for the transcription factor activator protein-1 (AP-1) have been identified in the promoter region of NOS I gene (Rife et al., 2000) , and Ang II activates AP-1 in the heart and cultured cardiac myocytes (Tadevosyan et al., 2010) . Thus, it is conceivable that AP-1 may act as the interface between AT1R activation and NOS I transcription in the RVLM during phase I mevinphos intoxication. The present study also revealed that AT1R-mediated oxidative stress in the RVLM plays a crucial role in sustaining brain stem cardiovascular regulation and survival after mevinphos intoxication. A beneficial role for Ang II in cell fate via AT1R activation is demonstrated in the promotion of cell growth or proliferation in breast cancer MCF-7 cells or cultured rat cardiac fibroblasts (Wang et al., 2013) . Our laboratory reported previously (Chan et al., 2011) that mevinphos induces hypoxia and upregulation of hypoxia-inducible factor in the RVLM during phase I mevinphos intoxication. Furthermore, hypoxia or anoxia elicits oxidative stress in rat brain stem (Martin et al., 2011) or neuronal PC12 cells (Yuan et al., 2004) ; blockade of AT1R prevents hypoxia-induced increase of oxidative stress in human plasma (Pialoux et al., 2011) . Thus, the possibility exists, subjected to validation, that mevinphos-induced hypoxia may underlie oxidative stress via AT1R activation in the RVLM.
The present study also demonstrated that AT2R in the RVLM plays an opposite role against AT1R during mevinphos intoxication, as has been reported in cell proliferation, differentiation, or cell death (Miura et al., 2009) . We showed that activation of AT2R is upstream to the augmentation of peroxynitrite formed by a reaction between NOS II-derived NO and superoxide, which we demonstrated previously to underlie the impairment of brain stem cardiovascular regulation and fatality during mevinphos intoxication. Furthermore, activation of the transcription factor nuclear factor-κB (NF-κB) leads to upregulation of NOS II in the RVLM during mevinphos intoxication . We noted that activation of NF-κB by Ang II is also observed in the heart and cultured cardiac myocytes (Tadevosyan et al., 2010) , and two NF-κB binding sites are present in the NOS II promoter (Chen et al., 2012) . Thus, it is also conceivable that NF-κB may serve as the intermediate between activation of AT2R and transcriptional upregulation of NOS II in the RVLM during mevinphos intoxication.
Oxidative stress contributes to mortality in patients suffering from cardiovascular disease (Postorino et al., 2008) and FIg. 9. Phasic changes of activity of PP2A and levels of NOS I or NOS II and ERK or phosphorylated ERK in fold relative to vehicle + aCSF group detected in the RVLM of rats that received pretreatment by microinjection into the bilateral RVLM of aCSF or 0.2% DMSO (Veh), Los, PD, Los + PD, or okadaic acid (OA; 5 fmol; PP2A inhibitor), 30 min before local application of aCSF or Mev to the bilateral RVLM. Values are mean ± SEM of triplicate analyses from four to six animals per experimental group. *p < 0.05 versus Veh + aCSF group, and + p < 0.05 versus Veh + Mev group at corresponding time points in the Scheffé multiple-range test.
in animals succumbed to sepsis induced by cecal ligation and puncture or lipopolysaccharide (Lin et al., 2005) . Oxidative stress also contributes to cell death in neuronal cells treated with hydrogen peroxide (Magliaro and Saldanha, 2009 ). These observations therefore seemingly contradict our present finding. One reasonable explanation for the doubleedged sword actions of oxidative stress during mevinphos intoxication offered by our results is the transition from AT1R-mediated oxidative stress to AT2R-mediate nitrosative stress in the RVLM. The preferential upregulation of AT1R and Nox during phase I in the face of the progressive augmentation of AT2R and NOS II expression suggested that the key determinant of this transition is formation of peroxynitrite in the RVLM. Our results indicated that after the blockade of AT1R in the RVLM during mevinphos intoxication, activation of AT2R in the RVLM becomes the key player to elicit nitrosative stress, followed by impairment of brain stem cardiovascular regulation and death. This notion was supported by a reduced augmentation of superoxide (Fig. 5) after blockade of AT2R or both AT1R and AT2R and by further potentiation of superoxide (Fig. 5) after blockade of AT1R in the RVLM. More importantly, our observations that the fatal effects of AT1R blockade was accompanied by significantly increased AT2R mRNA level and nitrosative stress in the RVLM during phase I indicated that a cross talk between AT1R and AT2R may hold the key to this determinant. Our results further revealed at least two intracellular mechanisms are responsible for this cross talk. One is AT1R-mediated inhibition of AT2R transcription, and the other is AT2R-mediated PP2A activation that leads to inhibition of ERK and NOS I phosphorylation in the RVLM. It has been reported that, in the presence of AT1R blockade, Ang II induces significant vasodilation of precontracted rat aorta (Lee et al., 2008) via AT2R-dependent upregulation of NOS II mRNA or protein and NO production. Application of lipopolysaccharide into the RVLM elicited hypotension, alongside a decrease of AT1R and an increase in NOS II mRNA and protein (Chan et al., 2003) . Furthermore, after AT1R blockade, AT2R mRNA is significantly increased and mediates relaxation in rat aorta (Cosentino et al., 2005) . PP2A is a key component of the intracellular pathways coupled to neuronal AT2R (Huang et al., 1996) , and activation of ERK upregulates NOS I (Chang, 2012) . Of note is that AT2R-transfected CHO cells exhibit decreased ERK2 phosphorylation (Moore et al., 2004) , and application of PP2A inhibitor enhances NOS I in NG108-15 cells (Komeima et al., 2000) .
The present study was undertaken to provide further insights into the cellular and molecular mechanisms (Costa, 2006) that underlie the sometimes fatal cardiovascular depressive effects of organophosphate poisoning. Using mevinphos intoxication as an illustrative example, we conclude that the progression from sustained to impaired brain stem cardiovascular regulation, the shift from maintained to depressed AP and HR, and the shift from survival to fatality seen during organophosphate poisoning can be accounted for by a transition from AT1R-mediated oxidative stress to AT2R-mediated nitrosative stress in the RVLM. We further showed that the key determinant of this transition is formation of peroxynitrite in the RVLM, and a cross talk between AT1R and AT2R 
FIg. 12.
Phasic changes of mRNA levels of AT1R or AT2R in fold relative to vehicle + aCSF group detected in the RVLM of rats received pretreatment by microinjection into the bilateral RVLM of aCSF (Veh), Los, or PD, 30 min before local application of aCSF or Mev to the RVLM. Values are mean ± SEM of triplicate analyses from four to six animals per experimental group. *p < 0.05 versus Veh + aCSF group, and + p < 0.05 versus Veh + Mev group at corresponding time points in the Scheffé multiple-range test. 214 may hold the key to this determinant. Despite repeated dosing of atropine, the time-honored treatment that targets against the overstimulated cholinergic receptors, some patients still succumbed to acute organophosphate poisoning (Yen et al., 2000) . Therefore, our demonstration of a pivotal role for AT1R and AT2R in the RVLM in organophosphate poisoning offers a new vista in devising therapeutic strategy for its clinical management.
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